广济药业：2025年前三季度净利润约-9730万元

Company Performance - Guangji Pharmaceutical reported a revenue of approximately 429 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 7.12% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 97.3 million yuan [1] - The basic earnings per share showed a loss of 0.2789 yuan [1] Market Capitalization - As of the report, Guangji Pharmaceutical's market capitalization stands at 2.4 billion yuan [1]